MedPath

Dextrose Monohydrate

Approved
Approval ID

fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2022

Manufacturers
FDA

International Medication Systems, Limited

DUNS: 055750020

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dextrose Monohydrate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76329-3302
Application NumberANDA203451
Product Classification
M
Marketing Category
C73584
G
Generic Name
Dextrose Monohydrate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 11, 2021
FDA Product Classification

INGREDIENTS (4)

SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
Dextrose monohydrateActive
Quantity: 25 g in 50 mL
Code: LX22YL083G
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dextrose Monohydrate - FDA Drug Approval Details